
COVID-19: CRO – Financial Health Check
Project managers need to demonstrate to their management how funds are being spent in clinical trials and the ability to avoid costs increases where possible. Understand your next change order as a chance to reshuffle the cards and to play your trump card.

CRO Change Order received! – Why Worry?
Project managers need to demonstrate to their management how funds are being spent in clinical trials and the ability to avoid costs increases where possible. Understand your next change order as a chance to reshuffle the cards and to play your trump card.

CILIQUE is attending Healthtech Invest Europe 2017
Healthtech Invest Europe 2017 will take place on 15-16 March 2017 in Helsinki, bringing together leading investors from Europe and some of the most promising Health Tech entrepreneurs of Europe and Finland. The event will concentrate on the following subsectors: Medical Devices & Diagnostics Digital Health Connected Health & Sensors Wearables and Well-Being Technology 40 of the best European early […]

Clinical Development Likelyhood of Approval tripple when using Biomarkers
Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to 8.4% when no selection biomarkers were used. This one of the results of the largest ever study of clinical development success rates released by the Biotechnology Innovation Organization (BIO). The study, conducted in partnership with Amplion […]

How effective is your CRO and Vendor Oversight ?
Oversight is YOUR responsibility no matter what you outsource and to which vendors you work with. You are accountable fully in the eyes of healthcare regulators and Patients alike. You can join this webinar from MACROCARE to explore some best practices and benchmark how you are doing currently on risk management and compliance areas that feed […]

60% cheaper clinical trials in Australia compared to US
Conducting clinical trials in Australia could save up to 60% of the average clinical trial costs compared to the US. That is the outcome of a report published by Frost & Sulivan, which can be accessed on the website of Novotech. Novotech is partnering with Deloitte to brief early stage companies to take advantage of this […]

The Changing Role of the CRO and its Effect on Project Management
The increased complexity of clinical trials places greater strategic demands on CROs and project managers (PMs). To ensure operational excellence and financial profitability under an ever-changing and challenging clinical trial environment, the role and profile of the PM needs to continuously evolve beyond the management of the “triple constraint.”. The competencies of the PM in […]

David or Goliath? – Is a Bigger CRO Better?
The importance of midsized CROs in pharmaceutical and medical device development. It’s no surprise to industry insiders that the largest pharmaceutical companies rely on the largest contract research organizations (CROs) for the lion’s share of their outsourced R&D. For example, in the first quarter of 2015, 34% of ICON’s total revenue (approximately $134 million of […]

Free online Training: Refocusing on Risk Mitigation in Starting Clinical Trials
The webinar will focus on study startup and discuss best practices for the identification and mitigation of potential risks before they occur. To join and listen to this training just submit your name and email address to us and you can join the training now and at any time in the future. Start the video […]

WEBINAR: Implementing Earned Value Analysis (EVA) in clinical trials
CILIQUE provides an online training about Earned Value Analysis in Clinical Trials. Earned value management (EVM), or Earned value project/performance management (EVPM) is a project management technique for measuring project performance and progress in an objective manner. It has the ability to combine measurements of the project management triangle: Scope Time Costs In a single integrated […]